Antimicrobial Activity of Cefepime-Tazobactam Combination against Extended Spectrum Beta-Lactamase and/or AmpC Beta-Lactamase- Producing Gram-negative Bacilli

Author:

Elawady Basma Ahmed1,Mahmoud Noha Refaat2,Badawi Hala El-Sayed2,Badr Azza Essam Eldin1,Gohar Noha Mahmoud1

Affiliation:

1. Cairo University

2. Theodor Bilharz Research Institute, Cairo, Egypt

Abstract

Abstract

Background The problem of resistance to beta-lactam antibiotics, which is caused by ESBL and AmpC β-lactamases, is getting worse globally. Infections caused by bacterial isolates harboring these enzymes are difficult to treat with carbapenems being the sole effective treatment option for such infections. The objective of this study was to assess the sensitivity of the cefepime-tazobactam combination against ESBL- and/or AmpC-producing Gram-negative bacilli. Methods This is an observational cross-sectional study carried out on 100 Gram-negative bacilli. ESBL production was screened by using the disc diffusion test followed by confirmation by the combined disc confirmatory test, the screening for AmpC production was conducted using the cefoxitin disc test, which was subsequently confirmed by the AmpC disc test. Isolates confirmed positive for ESBL and/ or AmpC production were investigated for their susceptibility to antibiotics. Results Among 100 Gram-negative bacilli, 44 isolates were confirmed as ESBL producers by the combined disc confirmatory test out of 56 isolates that tested positive for ESBL production through the disc diffusion test. The presence of AmpC production was assessed using the cefoxitin disc test, 32 isolates were screened to be AmpC producers, and the AmpC disc test confirmed AmpC production in 9 isolates of them. Using the Mast® D68C set, 32 isolates were ESBL producers, 3 were AmpC producers, and 4 isolates were ESBL/AmpC co-producers. The highest sensitivity was to cefepime-tazobactam (91.48%) followed by the carbapenems. Conclusion Cefepime-tazobactam showed remarkable activity against ESBL and/or AmpC-producing Gram-negative bacilli and may be considered as a therapeutic alternative to carbapenems.

Publisher

Research Square Platform LLC

Reference49 articles.

1. Antibiotic resistance;Frieri M;J Infect Public Health,2017

2. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications;Iredell J;BMJ,2016

3. Prevalence of Extended Spectrum Beta-lactamases and AmpC beta-lactamases in clinical isolates of gram-negative bacilli at a tertiary care hospital;Rao MJ;J Evol Med Dent,2018

4. Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing Gram-negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia;Tekele S;PLoS ONE,2020

5. The structure of b-lactamases;Ambler R;Philos Trans R Soc Lond B Biol Sci,1980

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3